SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotransplant(BTRN)
BTRN 35.400.0%Nov 28 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Icebrg who wrote (939)7/14/2001 3:21:35 PM
From: Icebrg  Read Replies (1) of 1475
 
Signals Magazine on the efforts to achieve Immune Tolerance.

Gambling On Immune Tolerance

For half a century, transplant surgeons have dreamed of tricking the immune system into accepting foreign organs without immunosuppression. Now government and industry have placed their chips on the table, launching a run of clinical trials designed to achieve tolerance in humans. This effort, unnoticed by the press and public, has the potential to transform organ transplantation and cure autoimmune disease. But it also could backfire disastrously.

signalsmag.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News